It seems fair to say that biotech hasn’t been the hottest of fields for much of this year. Money c... Read More
André Uddin from Research Capital Corporation is still tight with Theratechnologies (Theratechnolog... Read More
With its second quarter now in the books, André Uddin from Research Capital Corporation has maintai... Read More
Calling the company’s pipeline underappreciated, Mackie Research analyst André Uddin raised his t... Read More
Specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart, News TSX:TH) misse... Read More
On the basis of extended timelines for clinical testing, Echelon Wealth Partners analyst Douglas Loe... Read More
Mackie Research analyst André Uddin is staying bullish on specialty pharma company Theratechnologie... Read More
There’s good value to be had in 2020 from biotech stocks, says Eden Rahim of Next Edge Capital, wh... Read More
Specialty pharma company Theratechnologies (Theratechnologies Stock Quote, Chart News TSX:TH) has be... Read More
Mixed results from the company’s latest earnings has Mackie Research Capital Corporation analyst A... Read More
Earlier this year, Endocrinology drug developer Theratechnologies (Theratechnologies Stock Quote, Ch... Read More
Following a fresh set of results from Theratechnologies (Theratechnologies Stock Quote, Chart TSX:TH... Read More
Positive new data for Theratechnologies’ (Theratechnologies Stock Quote, Chart TSX:TH) HIV tre... Read More
Echelon Wealth Partners analyst Douglas Loe says the new acquisition by drug developer Theratechnolo... Read More
Mackie Research analyst André Uddin says that the new acquisition by specialty pharma company Thera... Read More
Commenting on Theratechnologies’ (TSX:TH) second quarter financials, André Uddin of Mackie Resear... Read More
Despite first quarter results that fell below expectations, Mackie Research Capital analyst André U... Read More
Echelon Wealth Partners analyst Doug Loe is sticking to his guns on Theratechnologies (Theratechnolo... Read More
Share
Tweet
pin
Share